1.Xuan Liu, Wanying Wu, Baohong Jiang, Min Yang, De-an Guo*, Pharmacological tools for the development of traditional Chinese medicine, TRENDS PHARMACOL SCI, 2013, 34(11): 620-628.
2.De-an Guo*, Wanying Wu, Min Ye, Xuan Liu, Geoffrey Cordell, A holistic approach to the quality control of traditional Chinese medicines, SCIENCE, 2015, 347 (6219 Suppl), S29-31.
3.Xiaojian Shi, Wenzhi Yang, Shi Qiu, Changliang Yao, Yao Shen, Qirui Bi, Min Yang, Wanying Wu, De-an Guo*. An in-source multiple collision-neutral loss filtering based nontargeted metabolomics approach for comprehensive analysis of malonyl-ginsenosides from Panax ginseng, P. quinquefolius, and P. notoginseng, ANAL CHIM ACTA, 2017, 952: 59-70.
4.QinHao Jin, JianQing Zhang, JinJun Hou, Min Lei, C Liu, X Wang, Y Huang, S Yao, BY Hwang, WY Wu, DA Guo. Novel C-17 spirost protostane-type triterpenoids from Alisma plantago-aquatica with anti-inflammatory activity in Caco-2 cells. ACTA PHARMACEUT SIN B, 2019, 9(4): 809-818.
5.Chang-liang Yao, Jian-qing Zhang, Jia-yuan Li, Wen-long Wei, Shi-fei Wu and De-an Guo*, Traditional Chinese Medicine (TCM) as a source of new anticancer drugs. NAT PROD REP, 2021 Jan 29. PMID: 33511969 doi: 10.1039/d0np00057d.